Global Intracranial Aneurysm Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others.By End Use;
Hospitals, Clinics, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Intracranial Aneurysm Market (USD Million), 2021 - 2031
In the year 2024, the Global Intracranial Aneurysm Market was valued at USD 1,153.25 million. The size of this market is expected to increase to USD 2,549.47 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
Global Intracranial Aneurysm Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 12.0 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 12.0 % |
Market Size (2024) | USD 1,153.25 Million |
Market Size (2031) | USD 2,549.47 Million |
Market Concentration | Low |
Report Pages | 364 |
Major Players
- Stryker Corporation
- MicroPort Scientific Corporation.
- Johnson & Johnson Services, Inc.
- MicroVention Inc.
- B. Braun Melsungen AG
- Integra LifeSciences
- RAUMEDIC AG
- Terumo Corporation
- Delta Surgical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Intracranial Aneurysm Market
Fragmented - Highly competitive market without dominant players
Market Overview
The intracranial aneurysm market is witnessing notable expansion, with projections indicating a rise from USD 1,029.69 million in 2023 to approximately USD 2,276.31 million by 2030. This reflects a steady compound annual growth rate (CAGR) of 12%, driven by the rising need for effective aneurysm treatment solutions and innovations in neurovascular care. Key Growth Drivers
The market’s momentum is fueled by several critical factors. The increasing prevalence of intracranial aneurysms—linked to aging populations and lifestyle risks such as smoking and high blood pressure—is a major contributor. Enhanced patient awareness and a greater focus on early diagnosis are also accelerating treatment demand. Moreover, medical technology improvements are delivering more precise and efficient options for both detection and intervention. Technological Innovations
Rapid advancements in medical technology are reshaping how intracranial aneurysms are diagnosed and treated. Enhanced imaging tools allow for earlier and more accurate detection, while AI-powered diagnostics support timely clinical decisions. In addition, the growing adoption of minimally invasive procedures is reducing recovery times and enhancing procedural success rates. Competitive Landscape
The intracranial aneurysm market is fairly consolidated, with key players leading through robust R&D investment. These companies are consistently introducing next-generation devices and therapies that aim to improve patient outcomes while minimizing procedural risks. Their focus on innovation and precision medicine is helping to set new benchmarks in the field of neurovascular health.
Global Intracranial Aneurysm Market Recent Developments
-
In October 2023, a study published in the BMJ Journal of Neurointerventional Surgery revealed that PreSize—an advanced AI-based software—outperformed human clinicians in accurately predicting stent placement within the brain. This breakthrough highlights the growing role of artificial intelligence in neurointervention and underscores its potential to enhance clinical precision. The success of AI tools like PreSize signals strong market growth opportunities for companies focused on innovative, data-driven treatment solutions in the intracranial aneurysm sector. Product Launch and Innovation
-
In June 2022, the Indian subsidiary of Medtronic plc launched the Pipeline Vantage Embolization Device for the treatment of brain aneurysms. This advanced device enhances blood flow diversion and offers improved support during complex neurovascular procedures. The introduction of this technology signifies a major step in providing cutting-edge aneurysm treatment options and reflects Medtronic’s dedication to delivering innovative neurointerventional solutions in growing healthcare markets.
Segment Analysis
In this report, the Global Intracranial Aneurysm Market has been segmented by Type, End Use, and Geography.
Global Intracranial Aneurysm Market, Segmentation by Type
The Global Intracranial Aneurysm Market has been segmented by Type into Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others.
Surgical Clipping
Surgical clipping remains one of the most widely used and effective treatments for intracranial aneurysms. This traditional method involves placing a clip at the base of the aneurysm to prevent rupture, particularly for large or complex aneurysms. The surgical clipping segment accounts for around 40% of the global market, with ongoing demand driven by its success in high-risk aneurysm cases and its well-established application in advanced healthcare settings.
Endovascular Coiling
Endovascular coiling is becoming increasingly popular due to its minimally invasive nature and reduced recovery times compared to surgical clipping. This procedure involves inserting soft platinum coils into the aneurysm via a catheter, effectively sealing it off to prevent rupture. The endovascular coiling segment holds a dominant market share of 45%, driven by a growing preference for non-invasive treatments and improved patient outcomes.
Flow Diverters
Flow diverters are a promising and innovative treatment for intracranial aneurysms, particularly effective in complex or large aneurysms that are difficult to treat using traditional methods. These devices redirect blood flow away from the aneurysm, allowing the vessel to heal naturally over time. The flow diverter segment accounts for about 10% of the market, reflecting the increasing adoption of these advanced technologies in treating challenging aneurysms.
Others
The "Others" segment encompasses various treatment alternatives for intracranial aneurysms, such as liquid embolic agents and stent-assisted coiling. Though it represents a smaller portion of the market at about 5%, this segment is growing as medical professionals explore additional options for patients with specialized needs or unusual aneurysm cases that do not respond well to conventional treatments.
Global Intracranial Aneurysm Market, Segmentation by End Use
The Global Intracranial Aneurysm Market has been segmented by End Use into Hospitals, Clinics, and Others.
Hospitals
Hospitals dominate the global intracranial aneurysm treatment market, contributing to 70% of the overall market share. These healthcare facilities are equipped with cutting-edge technology and offer a wide range of treatments, including complex procedures like surgical clipping and endovascular coiling. Hospitals play a vital role in the treatment of high-risk and emergency aneurysm cases, driving significant demand for advanced treatment options in these settings.
Clinics
Clinics are becoming an increasingly important segment in the intracranial aneurysm market, capturing around 20% of the market share. These outpatient settings often provide minimally invasive treatments such as endovascular coiling and flow diverter procedures, making them a preferred option for less complex cases and follow-up treatments. As awareness grows and demand for non-invasive procedures increases, clinics are playing a more significant role in aneurysm care.
Others
The "Others" segment, accounting for approximately 10% of the market, includes research institutions, specialized treatment centers, and facilities offering niche aneurysm treatments. This segment reflects the increasing diversity of healthcare settings that contribute to aneurysm care, with a growing number of patients seeking alternative treatments outside traditional hospitals and clinics.
Global Intracranial Aneurysm Market, Segmentation by Geography
In this report, the Global Intracranial Aneurysm Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Intracranial Aneurysm Market Share (%), by Geographical Region, 2024
North America
North America dominates the global intracranial aneurysm market, holding a substantial share of around 40%. This leadership is due to the region's robust healthcare infrastructure, extensive research initiatives, and the high prevalence of aneurysms in aging populations. The U.S. remains the major contributor, with continuous advancements in surgical techniques and endovascular treatments for aneurysms.
Europe
Europe ranks second, contributing approximately 30% to the global intracranial aneurysm market. The region boasts high standards of medical care, with advanced diagnostic and treatment options available for aneurysm patients. Countries like the U.K., Germany, and France are leaders in embracing minimally invasive procedures, further boosting the adoption of aneurysm treatments across Europe.
Asia Pacific
The Asia Pacific region is witnessing a rapid increase in demand for intracranial aneurysm treatments, accounting for around 15% of the global market. Factors such as improving healthcare systems, greater awareness of neurological conditions, and increasing patient access to advanced treatments are all driving this growth. Japan, China, and India are expected to be major players in the expansion of the market in this region.
Middle East and Africa
The Middle East and Africa (MEA) region contributes about 10% to the global intracranial aneurysm market. The market is still emerging, but there is a noticeable shift toward adopting advanced aneurysm treatment options. Increased healthcare investments, growing awareness about neurological disorders, and enhanced access to specialized care are expected to fuel growth in this region.
Latin America
Latin America holds approximately 5% of the global intracranial aneurysm market share. With improving healthcare infrastructure and access to advanced treatment options, the region is experiencing gradual market growth. Countries like Brazil and Mexico are expected to continue leading the way in adopting newer aneurysm treatment technologies as healthcare becomes more accessible in the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Intracranial Aneurysm Market. These factors include; Market Drivers, Restraints and Opportunities.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Rise in minimally invasive procedures demand
- Growing elderly population with neurological risks
- Increased use of advanced imaging techniques
- Rising awareness of aneurysm treatment options - Significantly contributing to the growth of the Global Intracranial Aneurysm Market. With an increase in knowledge about the condition, more patients are seeking early diagnosis and treatment options. This awareness helps reduce the fear and stigma associated with brain aneurysms, making individuals more likely to consult healthcare professionals at an earlier stage. Additionally, as medical information becomes more accessible through the internet, people are better informed about available therapies, leading to a greater demand for effective treatments. The accessibility of medical information has also played a crucial role in increasing awareness. As technology advances and online platforms continue to spread medical knowledge, patients are becoming more knowledgeable about conditions like intracranial aneurysms and the options available to manage them. This shift in how people acquire health-related information is crucial in creating a more proactive approach to treatment and healthcare management.
Public health campaigns and increased collaboration among healthcare providers have also heightened awareness of intracranial aneurysms. Hospitals, healthcare professionals, and advocacy groups are working together to inform the public about the risks associated with aneurysms and the importance of regular screenings. Such initiatives help educate patients about the benefits of early detection and the potential for better treatment outcomes, which fuels the demand for both surgical and non-surgical interventions.
Restraints:
- High cost of aneurysm treatments
- Risks linked to invasive surgeries
- Limited diagnosis in emerging regions
- Slow regulatory approval for innovations - The slow pace of regulatory approval poses a significant challenge to the growth of the Global Intracranial Aneurysm Market. Regulatory bodies, including the FDA in the U.S. and the EMA in Europe, require extensive clinical trials and in-depth evaluations to ensure new treatments are safe and effective for patients. While these procedures are crucial for patient safety, they can delay the launch of promising innovations, meaning that patients often face extended waiting periods before gaining access to potentially life-saving therapies. This delay hampers the timely availability of advanced treatments for intracranial aneurysms, despite their potential to improve outcomes.
Additionally, the prolonged approval process can prevent the adoption of groundbreaking therapies that could offer significant improvements over traditional methods. Innovations such as minimally invasive techniques and novel drug therapies may be delayed due to regulatory challenges. In turn, patients are left with older, less effective treatments, hindering progress in providing better alternatives for those at risk. The wait for new, approved solutions creates a gap in patient care, limiting access to more advanced treatment options that could potentially offer quicker recovery and reduced risks.
The slow approval process also disincentivizes investment in the development of new treatments for intracranial aneurysms. Medical companies often hesitate to invest heavily in research and development for treatments with uncertain approval timelines. If regulatory hurdles are perceived as particularly difficult or time-consuming, companies may focus their resources elsewhere, further limiting innovation in this field. As a result, fewer companies pursue novel approaches for aneurysm treatment, and the market experiences stagnation with fewer new products entering the marketplace.
Regulatory delays not only restrict patient access to advanced treatments but also affect the overall pace of market development. If approvals are delayed, the clinical applications of innovative therapies are postponed, preventing the market from benefiting from cutting-edge advancements. Therefore, enhancing the regulatory approval process could accelerate the introduction of life-changing solutions, benefiting both patients and healthcare providers by increasing treatment options and fostering a more dynamic and competitive market.
Opportunities:
- Growth in healthcare infrastructure worldwide
- Technological advancements in coiling devices
- Expanding telemedicine for early diagnosis
- Rising R&D in neurovascular therapies - Driving significant growth in the global intracranial aneurysm market. As advancements in neuroscience and medical technologies progress, innovative treatments and diagnostic approaches are being developed to enhance patient outcomes. Companies and research institutions are increasingly focused on advancing therapies that tackle the complexities of intracranial aneurysms, which are life-threatening conditions. This intensified focus on R&D is leading to the creation of safer and more effective treatments that improve patient survival rates and minimize risks associated with aneurysms.
The advancements in neurovascular technologies resulting from R&D are transforming the treatment landscape. Minimally invasive procedures, which are becoming more prevalent, not only offer a better patient experience but also improve treatment precision. Cutting-edge imaging systems like high-resolution MRI and CT scans, along with state-of-the-art surgical tools, are enabling earlier detection and more targeted interventions for aneurysms. These advancements allow healthcare providers to treat aneurysms in difficult-to-reach locations, thus improving both treatment access and success rates.
Additionally, R&D is contributing to the development of novel drug therapies aimed at managing aneurysms and preventing their rupture. Targeted drug delivery systems, designed to strengthen blood vessel walls or control blood pressure, are emerging as key treatments. These therapies hold the potential for long-term benefits by slowing the progression of aneurysms and even halting their growth. As these medications are further refined, they offer a non-invasive alternative to surgery, providing patients with more treatment options and improving their quality of life.
Collaboration between pharmaceutical companies, academic institutions, and healthcare providers is playing a pivotal role in translating these innovations from the laboratory to clinical practice. This collaborative effort is accelerating the development of new therapies and ensuring their swift introduction to the market. With continued investment in healthcare infrastructure and cutting-edge technologies, the neurovascular therapy field is expected to experience sustained growth. As a result, the market for intracranial aneurysm treatments will continue to evolve, providing patients with more personalized and accessible options for managing this serious condition.
Competitive Landscape Analysis
Key players in Global Intracranial Aneurysm Market include:
- Medtronic PLC
- Stryker Corporation
- Terumo Global (Microvention)
- Delta Surgical
- Integra Life-science Holding Corporation
- Spiegelberg
- Mizuho Medical Incorporation
- Evonos GmbH & Co. KG
- Microport Scientific Corporation
- B. Braun
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Intracranial Aneurysm Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rise in minimally invasive procedures demand
- Growing elderly population with neurological risks
- Increased use of advanced imaging techniques
- Rising awareness of aneurysm treatment options
- Drivers
- Drivers, Restraints and Opportunities
- Restraints
- High cost of aneurysm treatments
- Risks linked to invasive surgeries
- Limited diagnosis in emerging regions
- Slow regulatory approval for innovations
- Opportunities
- Growth in healthcare infrastructure worldwide
- Technological advancements in coiling devices
- Expanding telemedicine for early diagnosis
- Rising R&D in neurovascular therapies
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Market Segmentation
- Global Intracranial Aneurysm Market, By Type, 2021 - 2031 (USD Million)
-
Surgical Clipping
-
Endovascular Coiling
-
Flow Diverters
-
Others
-
- Global Intracranial Aneurysm Market, By End Use, 2021 - 2031 (USD Million)
-
Hospitals
-
Clinics
-
Others
-
- Global Intracranial Aneurysm Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Intracranial Aneurysm Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Stryker Corporation
- MicroPort Scientific Corporation.
- Johnson & Johnson Services, Inc.
- MicroVention Inc.
- B. Braun Melsungen AG
- Integra LifeSciences
- RAUMEDIC AG
- Terumo Corporation
- Delta Surgical
- Company Profiles
- Analyst Views
- Future Outlook of the Market